Global CGM Market will be US$ 5.6 Billion by 2025 | Renub Research
Continuous Glucose Monitor have significant advantages over other monitoring devices, especially for Type1 diabetes patients. It gives details for blood glucose continuously as compared to the traditional glucose monitor, which offers one time result
By: Renub Research
Due to all these several benefits of Continuous Glucose Monitor over other monitoring devices, this has become a vital device for management of diabetes, especially for Type1 diabetes patients. It gives details for blood glucose continuously as compared to the traditional glucose monitor, which offers one time result. Multiple medical device companies are investing heavily in the development of producing technologically advanced Contiguous Blood Glucose Monitor System to have a competitive advantage over other healthcare companies.
COVID-19 impact on Continuous Glucose Monitoring Systems
COVID-19 has affected global healthcare system, and diabetes management is one of them. Currently, healthcare facilities are focusing on the treatment of COVID-19 patients, and other patients are not receiving medical facilities as they were receiving in the past. Most of the health experts are providing consultation through telehealth systems.
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-
Phone No: +1 678-302-0700 (USA) | +91-120-421-
Follow the Link for Report Costomization: